Cargando…

Dialogue: Hydroxychloroquine pharmacokinetic (PK) and exposure response in pregnancies with systemic lupus erythematosus: the importance of adherence for neonatal outcome

Detalles Bibliográficos
Autores principales: Bermas, Bonnie, Costedoat-Chalumeau, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744101/
https://www.ncbi.nlm.nih.gov/pubmed/34996859
http://dx.doi.org/10.1136/lupus-2021-000630
_version_ 1784630049480114176
author Bermas, Bonnie
Costedoat-Chalumeau, Nathalie
author_facet Bermas, Bonnie
Costedoat-Chalumeau, Nathalie
author_sort Bermas, Bonnie
collection PubMed
description
format Online
Article
Text
id pubmed-8744101
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-87441012022-01-20 Dialogue: Hydroxychloroquine pharmacokinetic (PK) and exposure response in pregnancies with systemic lupus erythematosus: the importance of adherence for neonatal outcome Bermas, Bonnie Costedoat-Chalumeau, Nathalie Lupus Sci Med Dialogue BMJ Publishing Group 2022-01-07 /pmc/articles/PMC8744101/ /pubmed/34996859 http://dx.doi.org/10.1136/lupus-2021-000630 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Dialogue
Bermas, Bonnie
Costedoat-Chalumeau, Nathalie
Dialogue: Hydroxychloroquine pharmacokinetic (PK) and exposure response in pregnancies with systemic lupus erythematosus: the importance of adherence for neonatal outcome
title Dialogue: Hydroxychloroquine pharmacokinetic (PK) and exposure response in pregnancies with systemic lupus erythematosus: the importance of adherence for neonatal outcome
title_full Dialogue: Hydroxychloroquine pharmacokinetic (PK) and exposure response in pregnancies with systemic lupus erythematosus: the importance of adherence for neonatal outcome
title_fullStr Dialogue: Hydroxychloroquine pharmacokinetic (PK) and exposure response in pregnancies with systemic lupus erythematosus: the importance of adherence for neonatal outcome
title_full_unstemmed Dialogue: Hydroxychloroquine pharmacokinetic (PK) and exposure response in pregnancies with systemic lupus erythematosus: the importance of adherence for neonatal outcome
title_short Dialogue: Hydroxychloroquine pharmacokinetic (PK) and exposure response in pregnancies with systemic lupus erythematosus: the importance of adherence for neonatal outcome
title_sort dialogue: hydroxychloroquine pharmacokinetic (pk) and exposure response in pregnancies with systemic lupus erythematosus: the importance of adherence for neonatal outcome
topic Dialogue
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744101/
https://www.ncbi.nlm.nih.gov/pubmed/34996859
http://dx.doi.org/10.1136/lupus-2021-000630
work_keys_str_mv AT bermasbonnie dialoguehydroxychloroquinepharmacokineticpkandexposureresponseinpregnancieswithsystemiclupuserythematosustheimportanceofadherenceforneonataloutcome
AT costedoatchalumeaunathalie dialoguehydroxychloroquinepharmacokineticpkandexposureresponseinpregnancieswithsystemiclupuserythematosustheimportanceofadherenceforneonataloutcome